LY379268
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 532164

CAS#: 191471-52-0

Description: LY-379,268 is a potent and selective agonist for the group II metabotropic glutamate receptors (mGluR2/3). LY-379,268 has sedative, neuroprotective, anti-addictive and anticonvulsant effects in animals, and blocks the effects of PCP and DOI, which has led to research as antipsychotic drugs for the treatment of schizophrenia in animals.


Chemical Structure

img
LY379268
CAS# 191471-52-0

Theoretical Analysis

MedKoo Cat#: 532164
Name: LY379268
CAS#: 191471-52-0
Chemical Formula: C7H9NO5
Exact Mass: 187.05
Molecular Weight: 187.151
Elemental Analysis: C, 44.92; H, 4.85; N, 7.48; O, 42.74

Price and Availability

Size Price Availability Quantity
5mg USD 400 2 weeks
10mg USD 750 2 weeks
Bulk inquiry

Synonym: LY379268; LY 379268; LY-379268.

IUPAC/Chemical Name: (1S,2R,5R,6R)-2-amino-4-oxabicyclo[3.1.0]hexane-2,6-dicarboxylic acid

InChi Key: YASVRZWVUGJELU-MDASVERJSA-N

InChi Code: InChI=1S/C7H9NO5/c8-7(6(11)12)1-13-4-2(3(4)7)5(9)10/h2-4H,1,8H2,(H,9,10)(H,11,12)/t2-,3-,4+,7+/m1/s1

SMILES Code: O=C([C@@]1(N)[C@]2([H])[C@@H](C(O)=O)[C@]2([H])OC1)O

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Product Data:
Biological target: LY379268 is a potent, selective and brain-penetrant mGlu2/3R agonist with EC50 values of 2.69 nM (mGlu2) and 4.48 nM (mGlu3).
In vitro activity: This study aimed to determine whether LY379268, an mGlu3R agonist, exerts an antioxidant effect on aged cultured rat astrocytes. Treatment of 9w astrocytes with LY379268 resulted in an increase in mGlu3R and Nrf2 protein levels and SOD activity, and decreased mitochondrial ROS levels and apoptosis. Reference: Neurochem Int. 2020 Nov;140:104837. https://pubmed.ncbi.nlm.nih.gov/32858088/
In vivo activity: In testing the drug in rats as an analgesic to acute noxious stimuli, LY379268 (in doses up to 3 mg kg(-1) i.p.) did not affect withdrawal latencies to either mechanical or thermal stimulation. In a model of mouse tail withdrawal to warm water, LY379268 (12 mg kg(-1) i.p.), given before a subcutaneous tail injection of capsaicin, reduced the subsequent neurogenic hyperalgesia. Reference: Br J Pharmacol. 2002 Mar;135(5):1255-62. https://pubmed.ncbi.nlm.nih.gov/11877334/

Solubility Data

Solvent Max Conc. mg/mL Max Conc. mM
Solubility
Water 2.9 15.34

Preparing Stock Solutions

The following data is based on the product molecular weight 187.15 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol: 1. Turati J, Ramírez D, Carniglia L, Saba J, Caruso C, Quarleri J, Durand D, Lasaga M. Antioxidant and neuroprotective effects of mGlu3 receptor activation on astrocytes aged in vitro. Neurochem Int. 2020 Nov;140:104837. doi: 10.1016/j.neuint.2020.104837. Epub 2020 Aug 25. PMID: 32858088. 2. Hu YJ, Sun Q, Zhang WH, Huo YJ, Xu CJ, Liu JF. Specific activation of mGlu2 induced IGF-1R transactivation in vitro through FAK phosphorylation. Acta Pharmacol Sin. 2019 Apr;40(4):460-467. doi: 10.1038/s41401-018-0033-7. Epub 2018 Jun 26. PMID: 29946167; PMCID: PMC6461959. 3. Sharpe EF, Kingston AE, Lodge D, Monn JA, Headley PM. Systemic pre-treatment with a group II mGlu agonist, LY379268, reduces hyperalgesia in vivo. Br J Pharmacol. 2002 Mar;135(5):1255-62. doi: 10.1038/sj.bjp.0704583. PMID: 11877334; PMCID: PMC1573247. 4. Bond A, Jones NM, Hicks CA, Whiffin GM, Ward MA, O'Neill MF, Kingston AE, Monn JA, Ornstein PL, Schoepp DD, Lodge D, O'Neill MJ. Neuroprotective effects of LY379268, a selective mGlu2/3 receptor agonist: investigations into possible mechanism of action in vivo. J Pharmacol Exp Ther. 2000 Sep;294(3):800-9. PMID: 10945827.
In vitro protocol: 1. Turati J, Ramírez D, Carniglia L, Saba J, Caruso C, Quarleri J, Durand D, Lasaga M. Antioxidant and neuroprotective effects of mGlu3 receptor activation on astrocytes aged in vitro. Neurochem Int. 2020 Nov;140:104837. doi: 10.1016/j.neuint.2020.104837. Epub 2020 Aug 25. PMID: 32858088. 2. Hu YJ, Sun Q, Zhang WH, Huo YJ, Xu CJ, Liu JF. Specific activation of mGlu2 induced IGF-1R transactivation in vitro through FAK phosphorylation. Acta Pharmacol Sin. 2019 Apr;40(4):460-467. doi: 10.1038/s41401-018-0033-7. Epub 2018 Jun 26. PMID: 29946167; PMCID: PMC6461959.
In vivo protocol: 1. Sharpe EF, Kingston AE, Lodge D, Monn JA, Headley PM. Systemic pre-treatment with a group II mGlu agonist, LY379268, reduces hyperalgesia in vivo. Br J Pharmacol. 2002 Mar;135(5):1255-62. doi: 10.1038/sj.bjp.0704583. PMID: 11877334; PMCID: PMC1573247. 2. Bond A, Jones NM, Hicks CA, Whiffin GM, Ward MA, O'Neill MF, Kingston AE, Monn JA, Ornstein PL, Schoepp DD, Lodge D, O'Neill MJ. Neuroprotective effects of LY379268, a selective mGlu2/3 receptor agonist: investigations into possible mechanism of action in vivo. J Pharmacol Exp Ther. 2000 Sep;294(3):800-9. PMID: 10945827.

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Karkhanis AN, Beveridge TJ, Blough BE, Jones SR, Ferris MJ. The individual and combined effects of phenmetrazine and mgluR2/3 agonist LY379268 on the motivation to self-administer cocaine. Drug Alcohol Depend. 2016 Sep 1;166:51-60. doi: 10.1016/j.drugalcdep.2016.06.020. PubMed PMID: 27394931; PubMed Central PMCID: PMC5003316.

2: Engel M, Snikeris P, Matosin N, Newell KA, Huang XF, Frank E. Erratum to: mGluR2/3 agonist LY379268 rescues NMDA and GABAA receptor level deficits induced in a two-hit mouse model of schizophrenia. Psychopharmacology (Berl). 2016 Apr;233(8):1537. doi: 10.1007/s00213-016-4261-6. PubMed PMID: 26955838.

3: Engel M, Snikeris P, Matosin N, Newell KA, Huang XF, Frank E. mGluR2/3 agonist LY379268 rescues NMDA and GABAA receptor level deficits induced in a two-hit mouse model of schizophrenia. Psychopharmacology (Berl). 2016 Apr;233(8):1349-59. doi: 10.1007/s00213-016-4230-0. Erratum in: Psychopharmacology (Berl). 2016 Apr;233(8):1537. PubMed PMID: 26861891.

4: Myal S, O'Donnell P, Counotte DS. Nucleus accumbens injections of the mGluR2/3 agonist LY379268 increase cue-induced sucrose seeking following adult, but not adolescent sucrose self-administration. Neuroscience. 2015 Oct 1;305:309-15. doi: 10.1016/j.neuroscience.2015.07.077. PubMed PMID: 26241341; PubMed Central PMCID: PMC4559755.

5: Justinova Z, Le Foll B, Redhi GH, Markou A, Goldberg SR. Differential effects of the metabotropic glutamate 2/3 receptor agonist LY379268 on nicotine versus cocaine self-administration and relapse in squirrel monkeys. Psychopharmacology (Berl). 2016 May;233(10):1791-800. doi: 10.1007/s00213-015-3994-y. PubMed PMID: 26149611; PubMed Central PMCID: PMC4706511.